Accessibility Menu
 
Evotec Se logo

Evotec Se

(OTC) EVOTF

Current Price$5.24
Market Cap$931.21M
Since IPO (2004)+46%
5 Year-85%
1 Year-37%
1 Month-16%

Evotec Se Financials at a Glance

Market Cap

$931.21M

Revenue (TTM)

$756.33M

Net Income (TTM)

$158.98M

EPS (TTM)

$-0.99

P/E Ratio

-5.27

Dividend

$0.00

Beta (Volatility)

0.14 (Low)

Price

$5.24

Volume

10

Open

$5.24

Previous Close

$5.24

Daily Range

$5.24 - $5.24

52-Week Range

$4.72 - $8.58

EVOTF News

No articles available.

EVOTF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evotec Se

Industry

Life Sciences Tools and Services

Employees

4,788

CEO

Christian Wojczewski, PhD

Headquarters

Hamburg, 22419, DE

EVOTF Financials

Key Financial Metrics (TTM)

Gross Margin

11%

Operating Margin

-11%

Net Income Margin

-21%

Return on Equity

-17%

Return on Capital

-6%

Return on Assets

-9%

Earnings Yield

-18.98%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$931.21M

Shares Outstanding

177.71M

Volume

10

Short Interest

0.00%

Avg. Volume

26.918

Financials (TTM)

Gross Profit

$114.88M

Operating Income

$142.52M

EBITDA

$80.66M

Operating Cash Flow

$18.22M

Capital Expenditure

$132.24M

Free Cash Flow

$114.02M

Cash & ST Invst.

$396.80M

Total Debt

$443.54M

Evotec Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$163.89M

-11.4%

Gross Profit

$62.00K

-100.3%

Gross Margin

-0.04%

N/A

Market Cap

$931.21M

N/A

Market Cap/Employee

$195.39K

N/A

Employees

4,766

N/A

Net Income

$43.09M

-8.7%

EBITDA

$17.64M

+10.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$247.35M

-170.2%

Accounts Receivable

$155.68M

+13.8%

Inventory

$31.18M

-12.8%

Long Term Debt

$387.74M

-6.9%

Short Term Debt

$96.87M

+80.9%

Return on Assets

-8.97%

N/A

Return on Invested Capital

-6.11%

N/A

Free Cash Flow

$87.77M

-715.3%

Operating Cash Flow

$67.56M

-258.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNMLFGenomma Lab Internacional, S.A.B. de C.V.
$1.00+0.00%
TCNNFTrulieve Cannabis Corp.
$5.25-8.22%
TWAPFTowa Pharmaceutical Co., Ltd.
$16.83+0.00%
KSPHFKissei Pharmaceutical Co., Ltd.
$25.77+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About EVOTF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.